Below you will find peer-reviewed publications and references related to EmboCept® and its clinical applications.
Reviews and Guidelines
Rozzanigo, U.et al. Chemoembolization with Degradable Starch Microspheres (DSM-TACE). Expanding indications in HCC multidisciplinary tumor board. Hepatoma Research9, 14; 10.20517/2394-5079.2022.66 (2023). Explore more
Lucatelli, P.et al. CIRSE Standards of Practice on Hepatic Transarterial Chemoembolisation. Cardiovasc Intervent Radiol44, 1851–1867; 10.1007/s00270-021-02968-1 (2021).
Treatment of hepatocellular carcinoma (HCC)
Auer, T. A.et al. Trans-arterial chemoembolization with degradable starch microspheres (DSM-TACE) versus selective internal radiation therapy (SIRT) in multifocal hepatocellular carcinoma. Acta Radiol62, 313–321; 10.1177/0284185120926474 (2021).
Ludwig, J. M.et al. European Multicenter Study on Degradable Starch Microsphere TACE. The Digestible Way to Conquer HCC in Patients with High Tumor Burden. Cancers13, 5122 (2021). Explore more
Orlacchio, A.et al. Degradable starch microspheres transarterial chemoembolization (DSMs-TACE) in patients with unresectable hepatocellular carcinoma (HCC). Long-term results from a single-center 137-patient cohort prospective study. Radiol Med, 98–106; 10.1007/s11547-019-01093-x (2020).
Minici, R.et al. Safety and efficacy of degradable starch microspheres transcatheter arterial chemoembolization as a bridging therapy in patients with early stage hepatocellular carcinoma and Child-Pugh stage B eligible for liver transplant. Front. Pharmacol.12, 634084; 10.3389/fphar.2021.634084 (2021a). Explore more
Treatment of intrahepatic cholangiocellular carcinoma (ICC)
Goerg, F.et al. Chemoembolization with Degradable Starch Microspheres for Treatment of Patients with Primary or Recurrent Unresectable, Locally Advanced Intrahepatic Cholangiocarcinoma. A Pilot Study. Cardiovasc Intervent Radiol; 10.1007/s00270-019-02344-0 (2019).
Treatment of colorectal carcinoma (CRC) metastases in the liver
Vogl, T. J.et al. Transarterial chemoembolization of colorectal cancer liver metastasis. Improved tumor response by DSM-TACE versus conventional TACE, a prospective, randomized, single-center trial. Eur Radiol31, 2242–2251; 10.1007/s00330-020-07253-2 (2021).
Treatment of lung tumors
Vogl, T. J.et al. Transvenous pulmonary chemoembolization (TPCE) for palliative or neoadjuvant treatment of lung metastases. European radiology.
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. You also have the option to opt-out of these cookies. For more information about the cookies we use, see our Privacy Policy & Cookie Policy.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.